GlassScriptPhysician profile
Ralph Rodney Round
NPI 1821049511
$26,285.80
in general payments reported to CMS, 2019-2025
75 companies · $3,799 in 2025
The $3,799 reported for 2025 was more than what 82% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,749 · 2020: $2,924 · 2021: $3,888 · 2022: $3,727 · 2023: $4,032 · 2024: $4,166 · 2025: $3,799.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Education: $17.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,980.50 |
| Education | $17.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,331.57 | 2019-2025 | Ubrelvy, Botox, Qulipta |
| Novartis Pharmaceuticals Corporation | $1,515.27 | 2019-2025 | |
| Lilly USA, LLC | $1,338.25 | 2019-2025 | Emgality, Reyvow, Amyvid |
| Emd Serono, INC. | $1,268.92 | 2019-2025 | Mavenclad |
| Ucb, INC. | $1,199.07 | 2019-2025 | Fintepla, Zilbrysq, Rystiggo |
| Pfizer INC. | $1,029.64 | 2021-2025 | |
| Celgene Corporation | $1,005.35 | 2020-2025 | Zeposia |
| Biogen, INC. | $888.10 | 2019-2025 | Vumerity, Tysabri, Skyclarys |
| Mallinckrodt Hospital Products INC. | $824.43 | 2020-2025 | Acthar |
| Sk Life Science, INC. | $772.64 | 2020-2025 | Xcopri |
| Amgen INC. | $756.32 | 2019-2025 | Uplizna, Aimovig |
| Allergan, INC. | $731.72 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $685.03 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $640.54 | 2019-2022 | |
| Genzyme Corporation | $633.73 | 2019-2025 |
Show all 75 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ralph Round listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.